Treatment of Waldenstrom Macroglobulinemia with 2-Chlorodeoxyadenosine

Meletios A Dimopoulos

doi:10.7326/0003-4819-118-3-199302010-00007

Related publications

Article1993

Treatment of Waldenstrom's Macroglobulinemia with Nucleoside Analogues

Meletios A Dimopoulos, Susan O’Brien, Hagop M. Kantarjian, Elihu E. Estey, Michael J. Keating, Raymond Alexanian

Article1994

Primary Therapy of Waldenstriim's Macroglobulinemia With 2-Chlorodeoxyadenosine

Meletios A Dimopoulos, Hagop M. Kantarjian, Donna Weber, Susan O’Brien, Elihu H. Estey, Kay Delasalle, Esther Rose, Fernando Cabanillas, Michael M. Keating, Raymond Alexanian

Article1994

Primary therapy of Waldenström's macroglobulinemia with 2-chlorodeoxyadenosine.

Meletios A Dimopoulos, H. Kantarjian, D. Weber, S O'brien, E Estey, Kay Delasalle, Esther Rose, Fernando Cabanillas, M Keating, Raymond Alexanian

Article2000

Waldenström’s Macroglobulinemia: Clinical Features, Complications, and Management

Meletios A Dimopoulos, Panayiotis Panayiotidis, Lia A. Moulopoulos, Petros P. Sfikakis, Marinos C. Dalakas

Article2016

Treatment recommendations from the Eighth International Workshop on Waldenström’s Macroglobulinemia

Véronique Leblond, Efstathios Kastritis, Ranjana H. Advani, Stephen M. Ansell, Christian Buske, Jorge J. Castillo, Ramón García‐Sánz, Morie A. Gertz, Eva Kimby, Charalampia Kyriakou, Giampaolo Merlini, Monique C. Minnema, Pierre Morel, Enrica Morra, Mathias Rummel, Ashutosh Wechalekar, Christopher J. Patterson, Steven P. Treon, Meletios A Dimopoulos